Speciality plastic, fibre and foam products supplier Filtrona said it is well positioned to deliver growth for the full year as it reported a 24 per cent increase in half year revenue.
Revenue at constant FX grew to £324.8m for the half year ended 30 June 2012 from £268.6m the same time a year earlier. Like for like revenue increased 9% after progress at all its major divisions.
Pre-tax profit rose to £40.8m from £37.8m in the same period last year. Adjusted operating profit rose 26% while adjusted operating margin grew 30bps to 16.7%.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
"Given this performance, Filtrona remains well-positioned to deliver further balanced growth in 2012," said chief executive Colin Day.
Net debt rose to £183m from £145m previously, after the £36m acquisition spend on Lymtech Scientific, Jae Yong and Securit.
Filtrona raised its first-half dividend by 18% to 3.9p per share.
As at June 30, the group's gross pension liability was £27.1m, up from £12.7m a year earlier.
CJ
-
Saba Capital and Boaz Weinstein respond to investment trustsAs investment trust managers and industry experts accuse Saba of self-motivated opportunism, the hedge fund responds to specific "misleading claims" and sets out its stall
-
How to find top-quality companies with growing dividendsIan Mortimer, portfolio manager of Guinness Global Equity Income Fund, shares where he would put his money for sustainable and growing dividends
